# |
Company Name
|
Industry Name
|
Latest Price
(Rs.) |
Price Change
Rs (%) |
Market Cap
|
Net Sales
(Rs. Cr.) |
Latest EPS
(Rs.) |
Net Profit
Margin % |
Latest
P/E |
Latest
P/BV |
---|---|---|---|---|---|---|---|---|---|---|
Bank Of India | Bank - Public | 155.2 |
-0.4 (-0.26%) |
Mid Cap | 47,932 | 14.1 | 8.1 | 11.1 | 1.1 | |
Bandhan Bank | Bank - Private | 188.2 |
4.3 (2.34%) |
Mid Cap | 0 | - | - | - | - | |
Balkrishna Inds. | Tyres & Allied | 2,423.1 |
25.3 (1.06%) |
Mid Cap | 9,811 | 62.7 | 9.05 | 38.2 | 5.4 | |
Aurobindo Pharma | Pharmaceuticals& Drugs | 1,152.5 |
0.65 (0.06%) |
Mid Cap | 12,792 | 33.6 | 9.24 | 34.3 | 3.5 | |
AU Small Fin. Bank | Bank - Private | 633.4 |
-5.5 (-0.86%) |
Mid Cap | 1,429 | 24.3 | 53.23 | 26.3 | - | |
Astral | Plastic Products | 2,114.5 |
60.55 (2.95%) |
Mid Cap | 5,159 | 21.2 | 8.74 | 96.8 | 18.3 | |
Ashok Leyland | Automobiles-Trucks/Lcv | 192.6 |
7.25 (3.91%) |
Mid Cap | 36,144 | 8.4 | 3.55 | 22 | 5.8 | |
Apollo Tyres | Tyres & Allied | 511.9 |
17.5 (3.54%) |
Mid Cap | 17,301 | 18.9 | 3.18 | 26.2 | 3.1 | |
APL Apollo Tubes | Steel & IronProducts | 1,562 |
6.55 (0.42%) |
Mid Cap | 16,166 | 27.5 | 3.93 | 56.5 | 12.5 | |
Alkem Laboratories | Pharmaceuticals& Drugs | 4,837 |
-45.75 (-0.94%) |
Mid Cap | 9,055 | 140.3 | 12.31 | 34.8 | 5.5 | |
Ajanta Pharma | Pharmaceuticals& Drugs | 2,215 |
5.3 (0.24%) |
Mid Cap | 3,743 | 58.4 | 14.67 | 37.8 | 7.5 | |
AIA Engineering | Castings/Forgings | 3,776.6 |
9.2 (0.24%) |
Mid Cap | 4,909 | 121.2 | 20.1 | 31.1 | 5.5 | |
Aditya Birla Capital | Finance - NBFC | 231.4 |
-9.4 (-3.9%) |
Mid Cap | 27,416 | 10.4 | 17.6 | 23.2 | 2.5 | |
Adani Wilmar | Edible Oil | 357.5 |
14.15 (4.12%) |
Mid Cap | 55,262 | 1.7 | 1.34 | 203.2 | 5.5 | |
ACC | Cement &ConstructionMaterials | 2,531.3 |
5.15 (0.2%) |
Mid Cap | 17,768 | 124.4 | 3.69 | 20.3 | 2.9 | |
Abbott India | Pharmaceuticals& Drugs | 26,346.5 |
68.85 (0.26%) |
Mid Cap | 5,349 | 539.1 | 17.8 | 48.7 | 16.3 | |
3M India | Diversified | 30,280.1 |
365.2 (1.22%) |
Mid Cap | 3,733 | 442.3 | 11.49 | 67.6 | 15.3 |